Symptoms of hypoglycaemia include trembling, sweating, confusion, palpitations, hunger, irritability, and in severe cases, loss of consciousness or seizures
your clinician will apply the criteria relevant to your area
The long-term safety profile remains unknown and is not supported by any clinical trials
Not medically necessary : Injections prescribed without meeting the established medical criteria for obesity treatment
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: a randomized, double-blind, placebo-controlled clinical trial protocol